Open tender · Germany · Contract notice

Open house Arzneimittelrabattverträge Interferon beta-1a, Fertigarzneimittelbezeichnung Rebif(R), ATC L03AB07

AOK Bayern - Die Gesundheitskasse in Germany is inviting bids for “Open house Arzneimittelrabattverträge Interferon beta-1a, Fertigarzneimittelbezeichnung Rebif(R), ATC L03AB07”. Bids close on 3 June 2028.

The work

Non-exclusive discount agreements for Interferon beta-1a (Rebif(R), ATC L03AB07) with contracts starting from 01.08.2026 and ending on 31.07.2028.

Identical and non-negotiable discount agreements
Contract can be terminated with one month's notice
Agreement is superseded by a national or state-wide discount contract for the same substance

Key facts

Contract period: 01.08.2026 to 31.07.2028

What it takes to qualify

Worth a closer look

The tender is an 'open-house' model, not a formal procurement, and is not subject to procurement law.
The contract is concluded with all interested pharmaceutical companies who meet the eligibility criteria.
The contract can be terminated with one month's notice at the end of a month.

Policy conditions

No reservation, preference or local-content restriction.

Documents to submit

Eigenerklärung zur Zuverlässigkeitsigned declaration of reliability
Vertragsigned contract
Anlage "Festlegung der vertragsgegenständlichen Arzneimittel"signed attachment for drug specification
Handelsregisterauszugextract from commercial register to prove representation authority
Vollmachtpower of attorney if representation authority not from commercial register